Frank McCormick

Frank McCormick, Ph.D., director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, and associate dean of the UCSF School of Medicine, has signed a consulting agreement with SAIC-Frederick Inc. to work with the Frederick National Laboratory for Cancer Research (FNLCR), on behalf of the National Cancer Institute (NCI), to develop a proposal for intensive study of cancer cells driven by mutations of the RAS gene.

IRP XMRV Working Group, from left: Vineet KewalRamani, Ph.D., head, Model Development Section, DRP (NCI); Rachel Bagni, Ph.D., Molecular Detection and Viral Technology, PEL (SAIC-Frederick); Jeffrey Lifson, M.D., director, ACVP (SAIC-Frederick); Alan Rein, Ph.D., head, Retrovirus Assembly Section, DRP (NCI); James Hartley, Ph.D., head, Technology Development, PEL (SAIC-Frederick); Mary Kearney, Ph.D., head, Translational Research, DRP (NCI); and Stuart Le Grice, Ph.D., head, RT Biochemistry Section, DRP

In July 2012, members of a multidisciplinary research team of both SAIC-Frederick and NCI Center for Cancer Research scientists were recognized with the NIH Director’s Award for their outstanding work to rapidly evaluate a potential threat to the nation’s blood supply.